In brief

BMJ 2014; 348 doi: (Published 05 February 2014) Cite this as: BMJ 2014;348:g1318

England sees big fall in cervical cancer incidence: The rate of diagnosis of cervical cancer in England fell by 43% in 40 years from 15 new cases per 100 000 women in 1971 to nine per 100 000 in 2011. The death rate fell by 70% over the same period, from eight deaths per 100 000 women to two per 100 000 in 2011. In 2011 there were around 2500 new diagnoses of cervical cancer in England and 800 deaths.

Vaping is banned from Commonwealth Games: The Commonwealth Games, to be held in Glasgow in the summer, are to include electronic cigarettes in their smoking ban. The decision by the organisers comes after a consultation with public health authorities. Personal vaporisers will not be confiscated, but “vaping” will not be allowed in any of the venues or within their defined perimeters.

More drugs are added to cancer fund: Three drugs have been added to the drugs available through England’s cancer drugs fund: trastuzumab for breast cancer, radium-223 dichloride for prostate cancer; and dabrafenib for unresectable or metastatic melanoma. The fund provides an additional £200m (€240m; $330m) each year to enable patients with cancer in England to access drugs that are not routinely funded by their local NHS.

US drug regulator investigates safety of testosterone: The US Food and Drug Administration has announced that it is investigating the risk of stroke, heart attack, and death in men taking testosterone products. The decision has been promoted by the recent publication of two separate studies, it said, that each indicated an increased risk of cardiovascular events among men prescribed testosterone therapy.

Indian doctors are to be told to write drug names in capitals: The Medical Council of India has approved a notification telling doctors to write drug prescriptions in full capital letters. The notice will now need to be approved by the health ministry before it enters the rulebook for doctors nationwide. Sections of India’s medical community have often warned that a combination of illegible handwriting on prescriptions and similar sounding brand names of drugs for different illnesses could place patients at risk of receiving the wrong drugs.


Cite this as: BMJ 2014;348:g1318

View Abstract

Log in

Log in through your institution


* For online subscription